Table 1.

Subject characteristics

	IFN-α 2b-treated patients with melanoma	Untreated patients with melanoma	Healthy subjects	IFN-α 2b therapy, n (%)
				Adjuvant	Neoadjuvant
Subjects, n	22	22	20
Mean age, years	43.0	43.5	44.8
Sex, n (%)
Male	12 (55)	10	13
Female	10 (45)	12	7
Melanoma stage, n (%)
I	N/A	4 (18.3)	N/A	N/A	N/A
II	N/A	2 (9.2)	N/A	N/A	N/A
IIIA	12 (54.5)	2* (9.2)	N/A	12 (54.5)	0
IIIC	3 (13.7)	4* (18.3)	N/A	1 (4.5)	2 (9.1)
IV	7 (31.8)	10 (45)	N/A	4 (18.2)	3 (13.7)

N/A, not applicable; IFN-α 2b, interferon-α 2b.

*Refused treatment.